Fortress Biotech, Inc. (FBIO) NASDAQ
2.68
+0.11(+4.28%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.68
+0.11(+4.28%)
Currency In USD
| Market Cap | 102.12M |
| Enterprise Value | 97.04M |
| P/E Ratio | 0.66 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 1.35 |
| Price/Book Ratio | 0.52 |
| Enterprise/Revenue | -1.71 |
| Enterprise/EBITDA | 21.02 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 1.93 |
| Operating Margin | -0.84 |
| Return On Assets | 0.36 |
| Return On Equity | 1.64 |
| Revenue | 63.26M |
| Revenue/Share | 2.1 |
| Gross Profit | 42.34M |
| EBITDA | -20.17M |
| Net Income | 6.82M |
| Diluted EPS | -0.07 |
| Total Cash | 255.84M |
| Total Cash/Share | 8.11 |
| Total Debt | 53.63M |
| Total Debt/Equity | 0.33 |
| Current Ratio | 2.86 |
| Book Value Per Share | 6.42 |
| 52-Week Change | 45.65 |
| 52-Week High | 4.53 |
| 52-Week Low | 1.7 |
| Moving Average 50 Days | 2.5 |
| Moving Average 200 Days | 2.97 |
| Average Volume | 426,082 |
| Shares Outstanding | 33.22M |
| % Held by Institutions | 19.16 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
| Last Split Date | October 10, 2023 |